Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in head and neck cancer

Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in head and neck cancer - Biomarker analysis associated with diagnostic, recurrence, and therapeutic effects in head and neck cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042276

Enrollment

475

Registered

2020-10-30

Start date

2020-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and neck cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically diagnosed as head and neck cancer 2) Scheduled treatment at our hospital 3) 20 years old and over 4) Expected to survive for 120 days or more 5) The consent has been obtained

Exclusion criteria

Exclusion criteria: 1) Have a history or complication of other cancers 2) Judged as lacking consent due to dementia or mental illness 3)Patients who have decided inappropriate to include in this study by the investigators

Design outcomes

Primary

Measure	Time frame
1) Small RNAs associated with diagnosis 2) Investigate the relationship between the following items and the expression status of small RNAs <Patient background> Patient age, gender, primary site, stage, treatment method and information on results and course, information on recurrence and metastasis, information on unfollowable or termination due to transfer, etc.	—

Countries

Japan

Contacts

Public ContactYoshiko Kodani

MiRTeL Co.Ltd. Research and Development Division

kenkyu@mirtel.co.jp082-546-9797

Outcome results